American Research & Management Company’s Opiant Pharmaceuticals, Inc. Common Stock OPNT Stock Holding History

American Research & Management Company’s Portfolio OPNT Stock Details OPNT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	$3K	Hold	300	–	–	﹤0.01%	371
2022 Q2	$4K	Hold	300	–	–	﹤0.01%	348
2022 Q1	$6K	Hold	300	–	–	﹤0.01%	341
2021 Q4	$10K	Hold	300	–	–	﹤0.01%	307
2021 Q3	$8K	Hold	300	–	–	﹤0.01%	313
2021 Q2	$4K	Hold	300	–	–	﹤0.01%	353
2021 Q1	$3K	Hold	300	–	–	﹤0.01%	344
2020 Q4	$2K	Hold	300	–	–	﹤0.01%	360
2020 Q3	$2K	Hold	300	–	–	﹤0.01%	332
2020 Q2	$3K	Hold	300	–	–	﹤0.01%	321
2020 Q1	$3K	Hold	300	–	–	﹤0.01%	300
2019 Q4	$4K	Hold	300	–	–	﹤0.01%	309
2019 Q3	$5K	Hold	300	–	–	﹤0.01%	301
2019 Q2	$4K	Hold	300	–	–	﹤0.01%	320
2019 Q1	$4K	Hold	300	–	–	﹤0.01%	355
2018 Q4	$4K	Buy	+300	New	+$4.89K	﹤0.01%	306

Other funds holding OPNT

HealthInvest Partners Stockholm, Sweden $372M AUM 59.89% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

ACA

Apis Capital Advisors New York $648M AUM 302.67% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

SCM

Stonepine Capital Management Bend, Oregon $250M AUM 77.6% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

PHP

Parkman Healthcare Partners Stamford, Connecticut $970M AUM 79.46% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

American Research & Management Company's OPNT Position: Q3 2022 in Review

American Research & Management Company held its Opiant Pharmaceuticals, Inc. Common Stock (OPNT) position steady in Q3 2022 at 300 shares worth $3K. The position accounts for ﹤0.01% of the portfolio, ranked #371.

American Research & Management Company first reported a position in OPNT in Q4 2018 and has held it in 16 quarters since. The position peaked at $10K in Q4 2021. 32 funds tracked by Wall St. Rank hold OPNT as of Q3 2022.

American Research & Management Company held 300 shares of Opiant Pharmaceuticals, Inc. Common Stock worth $3K as of Q3 2022.
American Research & Management Company left its Opiant Pharmaceuticals, Inc. Common Stock share count unchanged in Q3 2022.
Opiant Pharmaceuticals, Inc. Common Stock made up ﹤0.01% of American Research & Management Company's portfolio in Q3 2022, its #371 holding.
American Research & Management Company first reported a position in Opiant Pharmaceuticals, Inc. Common Stock in Q4 2018 and has held it in 16 quarters since.
American Research & Management Company's Opiant Pharmaceuticals, Inc. Common Stock position peaked at $10K in Q4 2021.
32 funds tracked by Wall St. Rank held Opiant Pharmaceuticals, Inc. Common Stock as of Q3 2022.

Based on American Research & Management Company's 13F filing for Q3 2022, filed 7 Oct 2022.